# 1. Financial Performance ## A. Key Figures * **Revenue from Operations:** **₹3,187 Cr** (Q2 FY'26, +21% YoY) · **₹5,372 Cr** (H1 FY'26, +12% YoY) * **PBT:** **₹428 Cr** (Q2 FY'26, +11% YoY) · **₹613 Cr** (H1 FY'26, +23% YoY) * **PAT:** **₹324 Cr** (Q2 FY'26, +9% YoY) · **₹463 Cr** (H1 FY'26, +20% YoY) * **Subsidy Receipts:** **₹1,176 Cr** (Q2 FY'26) ## B. Revenue Growth * **Record Quarterly Performance:** Strongest-ever Q2 start driven by seasonal strength in fertilizers, with robust year-on-year and sequential top-line expansion. * **Sharp Sequential Rebound:** Revenue surged nearly **half** and PBT more than doubled quarter-on-quarter, reflecting strong operational leverage in peak season. ## C. Profit Margins * **Mixed Margin Trends:** Fertilizer segment profitability under pressure YoY from elevated raw material costs, despite higher realizations in P&K products. * **Cost Headwinds:** Significant input cost inflation, particularly in **ammonia (+150%)** and **sulphur (+123%)**, only partially offset urea realization decline. * **Future Margin Support:** In-house sulfuric acid availability expected to boost margins for ammonium sulphate and ammonium phosphate sulphate. --- # 2. Segment & Product Performance ## A. Key Figures * **Fertilizer Revenue:** **+21% YoY** (driven by DAP trading) * **Industrial Products Sales:** **₹618 Cr** (+13% YoY) * **Industrial EBIT:** **Profit of ₹54 Cr** (vs. loss of ₹17 Cr prior year) ## B. Fertilizer Sales * **Volume Expansion:** Strong double-digit revenue and volume growth in fertilizers, led by **significant DAP trading activity**. * **Ammonium Sulphate Outlook:** Expected volumes to decline meaningfully in FY '26 compared to FY '25, signaling a strategic shift or supply constraint. ## C. Industrial Products * **Profitability Rebound:** Industrial segment swung to profitability on higher traded product sales and **full-capacity operation of HX Crystal plant**, despite weak caprolactam margins. * **Margin Resilience:** EBIT improvement sustained amid narrowing caprolactam-benzene spread due to **cost optimization and favorable product mix**, including **melamine exports** with **20% higher realization** than domestic. * **Ammonia Trading Dynamics:** Ammonia trading contributes meaningfully to profits—**₹20 Cr in prior quarter**—with margins protected via **imported price-plus-delta contracts**, insulating against price volatility. * **Demand & Pricing Pressure:** Near-term demand seen as **stable**, but pricing pressure persists due to **low-cost Chinese imports**, particularly in select industrial products. ## D. HX Crystal Output * **Core Profit Driver:** HX Crystal is the **primary contributor to Q2’s ₹53 Cr profit**, leveraging HAS diversion from caprolactam and capturing strong export-oriented margins. * **Demand Outlook:** Domestic demand remains **soft**, but **export volumes expected to rise**, supporting continued high utilization and margin strength. --- # 3. Capacity & Production ## A. Key Figures * **Fertilizer Production Guidance:** **5–6 lakh tons** Q3 FY26 · **100% capacity utilization** targeted * **HX Plant Capacity:** **9,000 MT/year** (operating at full capacity) * **Sulfuric Acid V Project Capacity:** **198,000 tons/year** (commissioning in Q3) * Sulfuric Acid Capacity (Baroda): 5.7 lakh MT/year current · ~7.5 lakh MT/year post-expansion * **Capital Work in Progress:** **₹413 Cr** (as of H1 FY26) ## B. Plant Utilization * **Full Utilization Push:** Fertilizer production targeting **100% capacity** in Q3, supported by stable operations at HX plant running at **full capacity**. * **Input Security for Sikka:** 100% operation at Sikka contingent on securing **3–5 lakh tons PA of phosphoric acid** and **5 lakh tons of ammonia** annually. ## C. Sulfuric Acid Project * **Near-Term Commissioning:** Sulfuric Acid V project set for launch in Q3, enabling **cost-efficient production** of ammonium sulphate and ammonium phosphate sulphate at Vadodara. * **Integrated Efficiency Gains:** Steam byproduct to be utilized in Vadodara Complex; surplus acid unlikely to be monetized externally due to internal demand prioritization. * **Strategic Capacity Build:** Baroda’s sulfuric acid expansion to nearly triple effective capacity, reinforcing supply resilience for Sikka and other units. ## D. Urea Revamp Impact * **Short-Term Disruption, Long-Term Gain:** H1 production reached **55 lakh tons**, though Q4 revamp temporarily constrained urea output. * **Efficiency Upgrade Achieved:** Revamp completed June 2025, yielding **lower steam consumption** and improved plant efficiency. --- # 4. Supply & Input Costs ## A. Key Figures * **Phosphoric Acid Price:** **+20%** (imported) * **Sulphur Price:** **+150%** (surge in input cost) ## B. Raw Material Prices * **Cost Inflation Pressure:** Sharp increases in imported raw material costs, particularly phosphoric and sulfuric acid, weighed on growth momentum. * **Caprolactam Benzene Spread Outlook:** Expected to remain under pressure due to oversupply, a prolonged China shutdown, and enhanced US tariffs. * **Stable Pricing Regime:** No price revisions currently pending for raw phosphate, sulfates, RM, or finished DAP, supporting margin predictability. * **Ammonia Supply Stability:** Long-term contract ensures consistent supply at import price plus delta, preserving margin integrity. ## C. In-House Production * **Supply Chain Resilience:** Baroda complex is fully self-sufficient with in-house production of phosphoric acid and ammonia, insulating it from external market volatility. --- # 5. Demand & Seasonality ## A. Key Figures * **DAP Imports:** **>100,000 MT** imported to support market availability * **Trading Volumes:** **107,000 MT** primarily in DAP * **Q4 Benchmark:** ~**350,000 tons** manufacturing volume (prior year) referenced as guide ## B. Rabi Season Outlook * **Favorable Seasonal Demand:** Healthy Rabi season outlook driven by **optimal monsoon conditions**, **strong reservoir levels**, and **elevated support prices**, supporting robust agri-input demand. * **Supply-Driven Sales Execution:** Q3 sales expected to align with domestic production capacity, underpinned by comfortable opening inventories and government-backed import flows of DAP and urea. * **Resilient Operations:** Business remains unaffected by regional weather disruptions due to **pan-India presence across 15 states** and strategic product deployment. ## C. Trading & Product Dynamics * **Steady Melamine Demand:** Domestic and export demand for melamine holds firm, indicating stable industrial end-market conditions. * **Limited Price Impact:** Recent increase in DAP nutrient content (P&S up 10%) translates to only **5–7% price rise**, deemed non-material to demand or margins. ## D. Export & Import Activity * **Import-Led Market Support:** Large-scale DAP imports (>100,000 MT) executed under **4% government-mandated return on MRP**, ensuring supply security and predictable returns. --- # 6. Regulatory & Subsidy Risks ## A. Key Figures * **NBS Subsidy Rate Change:** **+10%** for phosphorus and sulphur nutrients · **7% to 1% reduction** for NPK fertilizers (composition-dependent) ## B. NBS Rate Changes * **Input Cost Pass-Through Uncertain:** Despite higher NBS rates for P and S nutrients and a revision for phosphoric acid, margin improvement in Q3 remains uncertain due to persistent cost pressures. * **Market Adaptation Complete:** Fertilizer market has fully adjusted to the revised NBS structure, with no further changes anticipated near-term. ## C. Subsidy Reimbursement * **Timely P&K and Urea Subsidy Receipts:** Subsidy dues received up to third week of September for both P&K and urea, indicating continued cash flow support. * **Pending Capital Cost Reimbursement:** Urea revamp project subsidy remains unfinalized; company awaits government decision on reimbursement of incurred costs. ## D. Government Talks * **Advocacy for Return on Net Worth:** GSFC is actively pushing for **return on net worth** recognition in subsidy calculations for revamp-related capital costs, currently under government review. * **Ongoing Push for Fixed Cost Compensation:** Discussions continue on fixed cost reimbursement, with GSFC preparing to present its case alongside other industry players. --- # 7. Guidance & Outlook ## A. Key Figures * **Q3 Sales Guidance:** **5–6 Lakh Tons** (includes trading volumes) ## B. Q3 Sales Forecast * **Sustainable Growth Trajectory:** Q3 sales on track with guidance, supported by strong business conditions and 40 days of positive momentum. * **Seasonal Strength Confirmed:** Management affirms Q2 and Q3 are **normally strong quarters**, aligning with historical performance patterns. ## C. Capex Plans * **Capex Roadmap Advancing:** Resumption of operations by **second week of October** enables progress on planned capital projects. * **Durable Profitability Drivers:** Margins to benefit from **ongoing cost optimization**, **urea revamping**, and **solar plant operations**—structural, not one-time, improvements. * **Ammonia Trading Continuity:** Margin contribution from ammonia trading expected to persist under current **term contract**, reinforcing earnings stability. * **Limited Near-Term Capex:** Beyond the **sulfuric acid V project**, no major capital projects planned; early-stage work on **Sikka DAP-to-NPK conversion** with minimal spend to date.